← Search

Data · dataset · 2026

Effects of ICMT and antioxidants on cancer development

Listed in ZivaHub and Deakin Research Online and DMU Figshare — shown once because both records carry DOI 10.69622/33368662

<p dir="ltr">Cancer development depends on both oncogenic mutations and the cellular and environmental conditions that support abnormal cell survival and growth.

Description

This thesis investigates two processes that influence cancer development: isoprenylcysteine carboxyl methyltransferase (ICMT)-dependent protein processing in BRAFⱽ⁶⁰⁰ᴱ-driven cancer and the effects of antioxidant exposure on tumor angiogenesis, spontaneous tumor development, and cellular transformation.</p><p dir="ltr">In <b>Paper I</b>, we examined whether ICMT supports BRAFⱽ⁶⁰⁰ᴱ-driven cancer growth and identified an ICMT substrate contributing to this dependency.

ICMT catalyzes the final methylation step in the processing of CAAX proteins, promoting their membrane association and signaling. Genetic and pharmacological inhibition of ICMT with UCM-1336 suppressed proliferation and invasion in BRAFⱽ⁶⁰⁰ᴱ-mutant melanoma cells and reduced tumor growth in xenograft and genetically engineered mouse models. BRAF inhibitor-resistant melanoma cells also remained sensitive to ICMT suppression.

Read the rest (8 more)

We then identified INPP5E as an ICMT-dependent substrate. ICMT inhibition reduced INPP5E methylation and membrane localization and increased PI(4,5)P2 at the plasma membrane. Restoring INPP5E to the membrane partly rescued growth defects caused by ICMT suppression.

These results indicate that BRAFⱽ⁶⁰⁰ᴱ-driven melanoma depends on ICMT partly because ICMT maintains the membrane localization and function of INPP5E.</p><p dir="ltr">In <b>Paper II</b>, we investigated how antioxidants influence tumor angiogenesis. We found that the redox-sensitive transcription factor BACH1 regulates a broad angiogenic gene program. Under normoxia, antioxidants increased BACH1 expression and induced angiogenesis-related gene expression in lung cancer cells and tumor organoids, with similar effects in xenograft tumors.

Hypoxia also increased BACH1 expression. HIFla contributed to this increase, but BACH1 could still activate angiogenesis-related genes in the absence of HIFla. Antioxidant treatment increased tumor vascularity, and this effect depended on BACH1.

Tumors with increased BACH1 were more sensitive to VEGFR2-targeted treatment, and BACH1 expression was associated with angiogenesis markers in human lung cancers. These results show that BACH1 links redox and oxygen conditions to the regulation of tumor angiogenesis.</p><p dir="ltr">In <b>Paper III</b>, we examined whether long-term antioxidant exposure affects spontaneous tumor development in wild-type mice. Lifelong dietary supplementation with vitamin E or ß-carotene, beginning during gestation, increased the incidence and number of gross tumors in FVB/N mice; the effect was smaller in C57BL/6N mice.

Tumors developed in several organs, with the lung being the most affected in FVB/N mice. In parallel, primary FVB/N mouse embryonic fibroblasts exposed to Trolox, a water-soluble vitamin E analog, during long-term culture showed persistent increases in proliferation and anchorage-independent growth. Only Trolox-exposed cells formed tumors after transplantation into NSG mice, without further Trolox administration.

At 6 months, RNA sequencing and follow-up experiments showed reduced p53-associated transcription and broader changes in proliferation and stress-response programs. These findings show that sustained antioxidant exposure can promote spontaneous tumor development in susceptible mouse backgrounds and favor persistent transformation-associated changes in primary cells.</p><h3 dir="ltr">List of scientific papers</h3><p dir="ltr">I. ICMT supports BRAFV600E-driven tumor growth by membrane targeting of the CAAX protein INPP5E<b>. </b><b>Yang, X.</b>, Qiao, X., Schmidt, S., Eklund, E. A., Ebner-Walter, C., Ivarsson, E., Crespo, M. A., Kersemakers, N., Dzanan, J. J., Thorisson, B., Lundgren, C., Lim, H. C., Shkoukani, S., Tüksammel, E., Xu, X., Sayin, V. I., Martín-Fontecha, M., Ortega-Gutiérrez, S., Dalin, M., & Bergo, M. O. (2026).

Proceedings of the National Academy of Sciences of the United States of America, 123(20), e2601795123. <a href="doi.org/10.1073/pnas.2601795123" target="_blank" rel="noreferrer">doi.org/10.1073/pnas.2601795123</a></p><p dir="ltr">II. Antioxidants stimulate BACH1-dependent tumor angiogenesis. Wang, T., Dong, Y., Huang, Z., Zhang, G., Zhao, Y., Yao, H., Hu, J., Tüksammel, E., Cai, H., Liang, N., Xu, X., <b>Yang, X.</b>, Schmidt, S., Qiao, X., Schlisio, S., Strömblad, S., Qian, H., Jiang, C., Treuter, E., & Bergo, M. O. (2023).

The Journal of Clinical Investigation, 133(20), e169671. <a href="doi.org/10.1172/JCI169671" target="_blank" rel="noreferrer">doi.org/10.1172/JCI169671</a></p><p dir="ltr">III. Long-term antioxidant administration increases spontaneous tumor development in FVB/N mice<b>. </b><b>Yang, X.</b>, Wiel, C., Qiao, X., Ebner-Walter, C., Crespo, M. A., Xie, G., Tüksammel, E., Schmidt, S., Xu, X., Lehmann, S., & Bergo, M. O. [Manuscript]</p>

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Cancer 75% · RNA sequencing 75% · Sequencing 75%
Provenance · 3 source records, 11 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3336866212 d agoJSON v1
Deakin Research Onlineoai:figshare.com:article/3336866212 d agoJSON v1
DMU Figshareoai:figshare.com:article/3336866212 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[disease].local:disease:cancerenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:earth-environmentalmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[field].local:field:earth-environmentalmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[modality].local:modality:rna-seqenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:sequencingenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
licensesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/rights
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title